Neither retinal nor brain atrophy can be shown in patients with isolated unilateral optic neuritis at the time of presentation

Multiple Sclerosis Journal

Volumn 17, Issue 1, 2011, Pages 89-95

  Kallenbach, Klaus ^a   Sander, Birgit ^a   Tsakiri, Anna ^a   Wanscher, Benedikte ^a   Fuglø, Dan ^a   Larsen, Michael ^a   Larsson, Henrik ^a   Frederiksen, Jette L ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Imaging; multiple sclerosis; optic neuritis; optical coherence tomography; retina; volumetric MRI

Indexed keywords

ADULT; ARTICLE; BRAIN ATROPHY; BRAIN SIZE; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE ASSOCIATION; EVOKED VISUAL RESPONSE; FEMALE; HIGH RISK PATIENT; HUMAN; ISOLATED UNILATERAL OPTIC NEURITIS; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; OBSERVATIONAL STUDY; OPTIC NEURITIS; OPTICAL COHERENCE TOMOGRAPHY; PROSPECTIVE STUDY; RETINA GYRATE ATROPHY; WHITE MATTER;

EID: 78650994737     PISSN: 13524585     EISSN: None     Source Type: Journal    
DOI: 10.1177/1352458510382017     Document Type: Article

References (44)

1. Trapp BD, Peterson J., Ransohoff RM, Rudick R., Mörk S. and Bö L. Axonal transection in the lesions of multiple sclerosis. N Engl J Med 1998 ; 338: 278-285.
2. Lassmann H., Suchanek G. and Ozawa K. Histopathology and the blood-cerebrospinal fluid barrier in multiple sclerosis. Ann Neurol 1994 ; 36 (Suppl): S42 - S46.
3. Rovaris M., Agosta F., Sormani MP, et al. Conventional and magnetization transfer MRI predictors of clinical multiple sclerosis evolution: a medium-term follow-up study. Brain 2003 ; 126: 2323-2332.
4. Ge Y., Grossman RI, Udupa JK, et al. Brain atrophy in relapsing-remitting multiple sclerosis and secondary progressive multiple sclerosis: longitudinal quantitative analysis. Radiology 2000 ; 214: 665-670.
5. Rudick RA, Fisher E., Lee JC, Duda JT and Simon J. Brain atrophy in relapsing multiple sclerosis: relationship to relapses, EDSS, and treatment with interferon beta-1a. Mult Scler 2000 ; 6: 365-372.
6. Sørensen TL, Frederiksen JL, Brønnum-Hansen H. and Petersen HC Optic neuritis as onset manifestation of multiple sclerosis: a nationwide, long-term survey. Neurology 1999 ; 53: 473-478.
7. Beck RW, Trobe JD, Moke PS, et al. High- and low-risk profiles for the development of multiple sclerosis within 10 years after optic neuritis: experience of the optic neuritis treatment trial. Arch Ophthalmol 2003 ; 121: 944-949.
8. O'Riordan JI, Thompson AJ, Kingsley DP, et al. The prognostic value of brain MRI in clinically isolated syndromes of the CNS. A 10-year follow-up. Brain 1998 ; 121 (Pt 3). 495-503.
9. Parisi V., Manni G., Spadaro M., et al. Correlation between morphological and functional retinal impairment in multiple sclerosis patients. Invest Ophthalmol Vis Sci 1999 ; 40: 2520-2527.
10. Trip SA, Schlottmann PG, Jones SJ, et al. Retinal nerve fiber layer axonal loss and visual dysfunction in optic neuritis. Ann Neurol 2005 ; 58: 383-391.
11. Sergott RC Optical coherence tomography: measuring in-vivo axonal survival and neuroprotection in multiple sclerosis and optic neuritis. Curr Opin Ophthalmol 2005 ; 16: 346-350.
12. Costello F., Coupland S., Hodge W., et al. Quantifying axonal loss after optic neuritis with optical coherence tomography. Ann Neurol 2006 ; 59: 963-969.
13. Fisher JB, Jacobs DA, Markowitz CE, et al. Relation of visual function to retinal nerve fiber layer thickness in multiple sclerosis. Ophthalmology 2006 ; 113: 324-332.
14. Rebolleda G., Noval S., Contreras I., Arnalich-Montiel F., García-Perez JL and Muñoz-Negrete FJ Optic disc cupping after optic neuritis evaluated with optic coherence tomography. Eye (Lond) 2009 ; 23: 890-894.
15. Pulicken M., Gordon-Lipkin E., Balcer LJ, Frohman E., Cutter G. and Calabresi PA Optical coherence tomography and disease subtype in multiple sclerosis. Neurology 2007 ; 69: 2085-2092.
16. Dalton CM, Brex PA, Jenkins R., et al. Progressive ventricular enlargement in patients with clinically isolated syndromes is associated with the early development of multiple sclerosis. J Neurol Neurosurg Psychiatry 2002 ; 73: 141-147.
17. Trip SA, Schlottmann PG, Jones SJ, et al. Optic nerve atrophy and retinal nerve fibre layer thinning following optic neuritis: evidence that axonal loss is a substrate of MRI-detected atrophy. Neuroimage 2006 ; 31: 286-293.
18. Grazioli E., Zivadinov R., Weinstock-Guttman B., et al. Retinal nerve fiber layer thickness is associated with brain MRI outcomes in multiple sclerosis. J Neurol Sci 2008 ; 268: 12-17.
19. Sepulcre J., Murie-Fernandez M., Salinas-Alaman A., García-Layana A., Bejarano B. and Villoslada P. Diagnostic accuracy of retinal abnormalities in predicting disease activity in MS. Neurology 2007 ; 68: 1488-1494.
20. Gordon-Lipkin E., Chodkowski B., Reich DS, et al. Retinal nerve fiber layer is associated with brain atrophy in multiple sclerosis. Neurology 2007 ; 69: 1603-1609.
21. Siger M., Dziegielewski K., Jasek L., et al. Optical coherence tomography in multiple sclerosis: thickness of the retinal nerve fiber layer as a potential measure of axonal loss and brain atrophy. J Neurol 2008 ; 255: 1555-1560.
22. Frohman EM, Dwyer MG, Frohman T., et al. Relationship of optic nerve and brain conventional and non-conventional MRI measures and retinal nerve fiber layer thickness, as assessed by OCT and GDx: a pilot study. J Neurol Sci 2009 ; 282: 96-105.
23. Kallenbach K., Simonsen H., Sander B., et al. Retinal nerve fiber layer thickness is associated with lesion length in acute optic neuritis. Neurology 2010 ; 74: 252-258.
24. Anon X. The clinical profile of optic neuritis. Experience of the Optic Neuritis Treatment Trial. Optic Neuritis Study Group. Arch Ophthalmol 1991 ; 109: 1673-1678.
25. Smith SM, Zhang Y., Jenkinson M., et al. Accurate, robust, and automated longitudinal and cross-sectional brain change analysis. Neuroimage 2002 ; 17: 479-489.
26. Smith SM, Jenkinson M., Woolrich MW, et al. Advances in functional and structural MR image analysis and implementation as FSL. Neuroimage 2004 ; 23 (Suppl 1). S208 - S219.
27. Neacsu V., Jasperse B., Korteweg T., et al. Agreement between different input image types in brain atrophy measurement in multiple sclerosis using SIENAX and SIENA. J Magn Reson Imaging 2008 ; 28: 559-565.
28. Miller DH, Barkhof F., Frank JA, Parker GJ and Thompson AJ Measurement of atrophy in multiple sclerosis: pathological basis, methodological aspects and clinical relevance. Brain 2002 ; 125: 1676-1695.
29. Ishikawa H., Stein DM, Wollstein G., Beaton S., Fujimoto JG and Schuman JS Macular segmentation with optical coherence tomography. Invest Ophthalmol Vis Sci 2005 ; 46: 2012-2017.
30. Brex PA, Jenkins R., Fox NC, et al. Detection of ventricular enlargement in patients at the earliest clinical stage of MS. Neurology 2000 ; 54: 1689-1691.
31. Paolillo A., Piattella MC, Pantano P., et al. The relationship between inflammation and atrophy in clinically isolated syndromes suggestive of multiple sclerosis: a monthly MRI study after triple-dose gadolinium-DTPA. J Neurol 2004 ; 251: 432-439.
32. Gallo A., Rovaris M., Riva R., et al. Diffusion-tensor magnetic resonance imaging detects normal-appearing white matter damage unrelated to short-term disease activity in patients at the earliest clinical stage of multiple sclerosis. Arch Neurol 2005 ; 62: 803-808.
33. Henry RG, Shieh M., Okuda DT, Evangelista A., Gorno-Tempini ML and Pelletier D. Regional grey matter atrophy in clinically isolated syndromes at presentation. J Neurol Neurosurg Psychiatry 2008 ; 79: 1236-1244.
34. Rocca MA, Agosta F., Sormani MP, et al. A three-year, multi-parametric MRI study in patients at presentation with CIS. J Neurol 2008 ; 255: 683-691.
35. Ceccarelli A., Rocca MA, Pagani E., et al. A voxel-based morphometry study of grey matter loss in MS patients with different clinical phenotypes. Neuroimage 2008 ; 42: 315-322.
36. Calabrese M., Atzori M., Bernardi V., et al. Cortical atrophy is relevant in multiple sclerosis at clinical onset. J Neurol 2007 ; 254: 1212-1220.
37. Good CD, Johnsrude IS, Ashburner J., Henson RN, Friston KJ and Frackowiak RS A voxel-based morphometric study of ageing in 465 normal adult human brains. Neuroimage 2001 ; 14: 21-36.
38. Outteryck O., Zephir H., Defoort S., et al. Optical coherence tomography in clinically isolated syndrome: no evidence of subclinical retinal axonal loss. Arch Neurol 2009 ; 66: 1373-1377.
39. Pueyo V., Martin J., Fernandez J., et al. Axonal loss in the retinal nerve fiber layer in patients with multiple sclerosis. Mult Scler 2008 ; 14: 609-614.
40. Thurtell MJ, Bala E., Yaniglos SS, Rucker JC, Peachey NS and Leigh RJ Evaluation of optic neuropathy in multiple sclerosis using low-contrast visual evoked potentials. Neurology 2009 ; 73: 1849-1857.
41. Pueyo V., Ara JR, Almarcegui C., et al. Sub-clinical atrophy of the retinal nerve fibre layer in multiple sclerosis. Acta Ophthalmol 2009 [Epub ahead of print].
42. Noval S., Contreras I., Rebolleda G. and Muñoz-Negrete FJ Optical coherence tomography versus automated perimetry for follow-up of optic neuritis. Acta Ophthalmol Scand 2006 ; 84: 790-794.
43. Gundogan FC, Demirkaya S. and Sobaci G. Is optical coherence tomography really a new biomarker candidate in multiple sclerosis? - A structural and functional evaluation. Invest Ophthalmol Vis Sci 2007 ; 48: 5773-5781.
44. Naismith RT, Tutlam NT, Xu J., et al. Optical coherence tomography is less sensitive than visual evoked potentials in optic neuritis. Neurology 2009 ; 73: 46-52.